The proposal was panned by healthcare groups that support price transparency in general but oppose the Trump administration’s approach.
Below are four reactions:
Editor’s Note: Responses were lightly edited for length.
Beth Feldpush, DrPH, senior vice president of policy and advocacy for America’s Essential Hospitals
“Posting negotiated rates will not benefit consumers, adds an administrative burden that competes for resources with patient care, and can harm competition and drive up prices. These policies undermine hospitals’ ability to negotiate equitable payments while giving consumers little actionable information with which to make informed care decisions.”
Blue Cross Blue Shield Association President and CEO Scott Serota
“As the Centers for Medicare and Medicaid Services noted in the proposed rule, the publication of negotiated rates for medical services may have negative, unintended consequences — including price increases — as clinicians and medical facilities could see in the negotiated payments a roadmap to bidding up prices rather than lowering rates.”
Federation of American Hospitals President and CEO Chip Kahn
“This final regulation on hospital transparency fails to meet the definition of price transparency useful for patients. Instead, it will only result in patient overload of useless information while distorting the competitive market for purchasing hospital care.
“Beyond these patient concerns, the fact is that this regulation exceeds the administration’s authority, and we plan on joining with hospitals to file a legal challenge.”
Joint statement from the American Hospital Association, Association of American Medical Colleges, Children’s Hospital Association and Federation of American Hospitals
The proposal “is a setback in efforts to provide patients with the most relevant information they need to make informed decisions about their care. Instead of helping patients know their out-of-pocket costs, this rule will introduce widespread confusion, accelerate anticompetitive behavior among health insurers, and stymie innovations in value-based care delivery.”
More articles on healthcare finance:
CMS unveils plans to resolve overcharges by Medicare Advantage insurers
Hospitals push for climate resiliency but face financial barriers, report shows
HealthPartners eliminating 75 jobs amid Medicare revenue decline
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
